Pituitary, Thyroid & Adrenal Disorders
Conference Coverage
Laser shrinks benign thyroid nodules
Major finding: A progressive nodule volume reduction was found at 6 months (–50.7%), 12 (–57.3%), and 24 (–60.9%) using laser ablation.
News
Sorafenib emerges as option for advanced thyroid cancer
Major finding: Median progression-free survival was 10.8 months with sorafenib and 5.8 months with placebo (P less than .0001). Data source:...
News
Sorafenib extends survival in differentiated thyroid cancer
Conference Coverage
Case Report: Chronic marijuana use potential cause for hypopituitarism
News
All glucocorticoids linked to increased risk of VTE
Major Finding: New use of systemic glucocorticoids was associated with the highest risk for VTE, with an estimated incidence rate ratio of 3.06,...
Conference Coverage
Subclinical hypothyroidism predicts cardiovascular mortality in NHANES
Major finding: Healthy adults with subclinical hypothyroidism had a 24% greater risk of cardiovascular death than did euthyroid individuals during...
News
Cancer deaths declined 20% since 1991
News
Clinical guidelines for hypothyroidism 'take the middle ground' on TSH
News
FDA approves pasireotide for Cushing's, with postmarketing safety studies
News
Thyroid Hormone Replacement Benefits Subset of CKD Patients
Major Finding: During a mean follow-up of 34.8 months, the overall rate of decline in estimated GFR was significantly greater among chronic kidney...